RxDoctor Payments Data

Sean McFadden, DO

Orthopaedic Surgery · Orlando, FLNPI 1538101522

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (41.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Reel Surgical, Inc. at 38.0% of the total. Reporting peaked in 2021 at $7,303 and has fallen 81.9% since, to $1,325 in 2025.

$18,691in general payments, 2019–2025

Across 104 payments — averaging $179.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Reel Surgical, Inc.$7K
  • Stryker$6K
  • Regeneron$3K
  • Arthrex$1K
  • Avanos Medical$317
  • Smith+Nephew$317
  • plus $802 from 11 others
$4,067,694in research payments, 2019–2025

Across 177 payments — averaging $22,981 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$3M
  • Endo Pharmaceuticals Inc.$754K
  • Ipsen Innovation$193K
  • Pacira Therapeutics, Inc.$139K

What the payments were for

  • Consulting fees$2,66014%
  • Travel & lodging$9765%
  • Food & beverage$6,58935%
  • Education$7,77142%
  • Gifts$6964%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,691 in reported general payments places this provider in the 70th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$314,455
Medicare patients
596
Services billed
2,453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium179$1,737
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen145$1,185
Ondansetron Hcl89$613
Methocarbamol85$490
Celecoxib19$362
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen32$359
Methylprednisolone44$297
Tramadol Hcl34$108
Meloxicam16$92

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →